|

Prizloncabtagene autoleucel (Prizlo-Cel) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: JNJ-90014496

Pipeline

Phase 1/2: 1

Top Sponsors

  • Janssen Research & Development, LLC1

Indications

  • Lymphoma, Large B-Cell, Diffuse1
  • Lymphoma, B-Cell1
  • Lymphoma, Non-Hodgkin1
  • Cancer1

Duarte, California1 trial

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

City of Hope

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.